NIPH: Operational Turnaround Disconnected From Extreme ValuationEl-Nile Co. for Pharmaceuticals & Chemical IndustriesEGX_DLY:NIPHmnmabroukw36ix📊 NIPH: Operational Turnaround Disconnected From Extreme Valuation 🧪 🏛️ Fundamentals: Strengths and Catalysts: Net profit turned around with +155% YoY growth due to price adjustments. 📈 State-backed contract security through HoldiPharma provides strong institutional positioning. 🏢 Regulatory drug repricing in Egypt acts as a direct revenue driver. 🚀 Weaknesses and Risks: Valuation shows an extreme disconnect at 69x P/E compared to the 15x sector average. ⚠️ Cash conversion remains low as capital is tied up in inventory revaluations. 💸 Raw material imports carry high foreign exchange risk and input inflation. 📉 Sharia Screen: Sharia status: Compliant, passing all financial ratio tests with interest-bearing debt at ~12.4% vs 30.0% limit. 🟢 📈 The Pulse: NIPH trades at EGP 332.00, up +231.3% YTD and +622.5% over the 1Y period. 📈 Extremely expensive price ratios require the stock to cool off further. 📊 Price needs to move sideways until company earnings catch up with high valuation multiples. ⏳ Strong selling pressure triggered a pullback till the 61.8% Fibonacci level at 327.00. 🔴 if Fibonacci breakdown happen, it will shifts the technical outlook from a pullback to a deeper correction. 📉 The next strong support level sits down near 179.00. 🟢 Reaching the 179.00 level would present a good potential entry point. 🎯 A breakdown below the 200-day moving average serves as the stop-loss signal for any entry at 179.00. 🛑 Existing position holders should protect capital and sell into any bullish pullback. 🛡️ 🧱 The Key Structural Boundaries • Immediate Resistance: EGP 327.00 broken Fibonacci 61.8% level. 🔴 • Primary Entry Support: EGP 179.00 strong support target. 🟢 • Stop-Loss Condition: Breaking below the 200-day moving average. 🛑 🎯 Verdict: Outstanding operational turnaround is fully priced into current stock multiples. ⚠️ Risk-reward stays balanced as technical indicators demand a deeper price cooling period. 📉 Avoid new entries until price tests key support or earnings bridge the valuation gap. 🟢 If you like my insights, follow and boost! 🙌💙🚀 🎁 $15 TradingView Discount: https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸🤑